The corporation, founded in 1997, is a company specialized in microorganism. We have developed an independent business in the field of microbiology in Korea, and produced various culture media for both aerobe and anaerobe. As the results of having devoted ourselves to develop better media, we have improved the high quality culture media and continued to develop new products.The field in which we, as an institute of immunology specialty, concentrate on intensive investment is diagnosis and treatment of corpulence and diabetes, the recent social issues. Another interesting fields are research and development of anti-cancer operation and immunity controller for immunity diseases like self-immunity disease, and these researches made the institute grow as a professional institute through developing those related cytokine and antibody. The action of immunity and antibody related to Osteoporosis were sold to Chemicon, a antibody specialized company. Along with the research for Adipokines secreted from corpulence tissues related to corpulence and the second type of diabetes, the mono or multi clone antibody related these proteins has been produced and is on the way of marketing contracts with various overseas specialized companies. Moreover, we have studied the diagnosis and treatment of Osteoporosis in association with the nation designated institute for Osteoporosis in Chosun University and discovered to get a patent for Osteoporosis control gene(TIZ) for the first time in the world. It is believed that these intensive research, development and investment will continuously lead the industry of Korea microorganism and the industry market of biomedical science successfully. With various and faithful academic support and service activity we will achieve the new ideology of customer satisfaction and appreciate all the customers for leading today of KOMED Corp.
